Access in all areas? a round up of developments in market access and health technology assessment: part 4
Journal of Comparative Effectiveness Research · 2024
DOI: 10.57264/cer-2024-0060 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Comparative Effectiveness Research, 2024. Verfasst von Alice Beattie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lane Clark & Peacock LLP, London, W1U 1DQ, UK. Hauptthemen laut MEDLINE: Technology Assessment, Biomedical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In this latest update, we look at recent developments in market access including the pricing agreement of Libmeldy ® by the Beneluxa Initiative, the financial impact of managed entry agreements in Italy and the restructuring of Agenzia Italiana del Farmaco (AIFA). We also highlight the collaboration between FINOSE and the New Expensive Drug (NED) section of the Nordic Pharmaceutical Forum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lane Clark & Peacock LLP, London, W1U 1DQ, UK.
- Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK.
Zitieren
APA
Beattie, A., Treharne, C., & Ramagopalan, S. V. (2024). Access in all areas? a round up of developments in market access and health technology assessment: part 4. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0060
Vancouver
Beattie A, Treharne C, Ramagopalan SV. Access in all areas? a round up of developments in market access and health technology assessment: part 4. Journal of Comparative Effectiveness Research. 2024. doi:10.57264/cer-2024-0060
BibTeX
@article{Beattie2024,
author = {Beattie, Alice and Treharne, Catrin and Ramagopalan, Sreeram V},
title = {Access in all areas? a round up of developments in market access and health technology assessment: part 4},
journal = {Journal of Comparative Effectiveness Research},
year = {2024},
doi = {10.57264/cer-2024-0060}
}
EUVIMED